CN107753749A - A kind of Chinese medicine for treating rheumatism - Google Patents
A kind of Chinese medicine for treating rheumatism Download PDFInfo
- Publication number
- CN107753749A CN107753749A CN201711186272.5A CN201711186272A CN107753749A CN 107753749 A CN107753749 A CN 107753749A CN 201711186272 A CN201711186272 A CN 201711186272A CN 107753749 A CN107753749 A CN 107753749A
- Authority
- CN
- China
- Prior art keywords
- herb
- parts
- chinese medicine
- bark
- japanese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a kind of Chinese medicine for treating rheumatism, its bulk drug weight composition is:In terms of 1000,700 ~ 900g of adder tongue herb, 100~300g of Herba adianti pedati, 500~600g of szechwan-Yunnan sanicle herb, 500~700g of adnate elder herb, 200~300g of common sesbania root and leaf, 500~900g of slenderstalk dicranostigma herb, 300~900g of delavay habenaria root, 700~1000g of japanese pagodatree bark, 800~1000g of japanese aralia bark.With functions dispelling wind and clearing away cold, removing dampness, relaxing tendons and activating collaterals, dredging collateral eliminating impediment, blood stasis dispersing and deswelling analgesic, anti-inflammatory of invigorating blood circulation, the effect of tonifying the liver and kidney.
Description
Technical field
The invention belongs to the field of Chinese medicines, is related to a kind of Chinese medicine for treating rheumatism.
Background technology
Rheumatism is one group of infringement joint, bone, muscle, blood vessel and about the disease based on soft tissue or connective tissue,
Wherein majority is autoimmune disease.Morbidity is much more hidden and slow, and the course of disease is longer, and has genetic predisposition mostly, diagnosis
And treatment acquires a certain degree of difficulty.Rheumatism clinical manifestation symptom has rheumatic arthritis, osteoproliferation, sciatica, bone to close
Save inflammation, neck-shoulder pain, lumbago and leg pain, scapulohumeral periarthritis, lumbar muscle strain, traumatic injury, muscle arthrosis swelling pain, extremity numbness, joint motion by
Limit joint stuffiness, ankylosing spondylitis and all kinds of degenerative osteoarthropathies etc..At present, treat above-mentioned disease medicine and method very
It is more, there are Chinese traditional treatment and western medical treatment, also there is therapy of combing traditional Chinese and Western medicine.Its Chinese and Western medicine is generally consolidated using Salicylic Acid Formulations and non-class
Alcohol formulations are diminished inflammation with pain of alleviation, and toxic side effect is larger, unsuitable long-term use of, and can only pain of alleviation, it is impossible to are thoroughly controlled
More;The traditional Chinese medical science is more to the treatment method of such illness, such as wind-dispelling, cold dispelling, dehumidify, moisturize, heat-clearing, purging intense heat, although with one
Fixed therapeutic action, but slowly effect, time length, expected therapeutic effect can not be played to intractable pain patient.
The content of the invention
It is an object of the present invention to the deficiency of the performance symptom and existing medicine for above-mentioned rheumatism, there is provided one kind tool
There is the Chinese medicine of unique curative treatment rheumatism, and with the advantages of having no toxic side effect.
Technical solution of the present invention is as follows:
A kind of Chinese medicine for treating rheumatism, its bulk drug weight composition are:In terms of 1000, the g of adder tongue herb 700~900, iron
7 100~300g of silk, 500~600g of szechwan-Yunnan sanicle herb, 500~700g of adnate elder herb, 200~300g of common sesbania root and leaf, the favus of the scalp
Spend 500~900g, 300~900g of delavay habenaria root, japanese pagodatree bark 700g~1000g, japanese aralia bark 800g~1000g.
The Chinese medicine of above-mentioned treatment rheumatism, its bulk drug weight composition are preferably:In terms of 1000, adder tongue herb 800g, iron
Seven 200g of silk, szechwan-Yunnan sanicle herb 500g, adnate elder herb 700g, common sesbania root and leaf 200g, slenderstalk dicranostigma herb 900g, delavay habenaria root 900g, japanese pagodatree bark
1000g, japanese aralia bark 1000g.
The Chinese medicine of present invention treatment rheumatism, can be made into the pharmaceutical dosage form of diversified forms, such as powder, pill or capsule.
The Chinese medicine of present invention treatment rheumatism, japanese aralia bark cure mainly expelling wind and activating blood flow, invigorating qi for tranquilization, strong smart nourshing kidney;Adder tongue herb energy
Clearing heat and cooling blood, analgesia, removing toxic substances;Szechwan-Yunnan sanicle herb energy wind-damp dispelling, relieving rigidity of muscles and joints;The dispelling wind and eliminating dampness of japanese pagodatree bark energy, swelling and pain relieving;Herba adianti pedati
Can Li Shui dehumidifying, treating stranguria analgesic;Adnate elder herb, common sesbania root and leaf, slenderstalk dicranostigma herb primary treatment wind-dispelling Li Shui, dissipate blood stasis and smoothing collaterals, swelling and pain relieving;
Delavay habenaria root strengthening lumbus and tonifying kidney, treatment kidney deficiency waist Tong.
Full side is taken a broad view of, there is functions dispelling wind and clearing away cold, removing dampness, relaxing tendons and activating collaterals, dredging collateral eliminating impediment, blood stasis dispersing and deswelling analgesic, promoting blood circulation anti-inflammatory, benefit
The effect of liver and kidney benefiting.With eliminating dampness and heat, based on wind-expelling pain-stopping, it is aided with removing pattogenic heat from the blood and toxic material from the body, promoting blood circulation and removing blood stasis and help product are evil just simultaneous
Care for, internal organs negative and positive of qi and blood can be made to reconcile, rheumatism heat evil is all removed, all card self-healing.Full presciption medicine it is mild-natured and, smell is suitable, compatibility mutual reinforcement between,
Mutually make to share, the effect of each medicine is original can be remarkably reinforced, not only effected a permanent cure but also took stopgap measures.
The Chinese medicine of present invention treatment rheumatism, its advantage are:Based on getting rid of illness, it is aided with the medicine supported just, treats both principal and secondary aspect of disease, strengthens
Immunity, fundamentally improve patient is susceptible to suffer from constitution.It the recurrence after healing can be avoided.Effectively preventing and treating, control and treatment rheumatism, property of medicine temperature
With, it is applied widely, while the damage to bones muscle etc. has significant curative effect;Quick, short treating period, cure rate is high, and effect is held
Long, pure Chinese medicine formula, have no toxic side effect, safe ready.
Embodiment
With reference to specific embodiment, the present invention will be described in detail.
Embodiment 1
A kind of Chinese medicine for treating rheumatism, its bulk drug weight composition are:In terms of 1000, adder tongue herb 800g, Herba adianti pedati 200g,
Szechwan-Yunnan sanicle herb 500g, adnate elder herb 700g, common sesbania root and leaf 200g, slenderstalk dicranostigma herb 900g, delavay habenaria root 900g, japanese pagodatree bark 1000g, thorn are old
Crow 1000g.Above-mentioned raw materials medicine is weighed up according to quantity, is prepared into pill.
Embodiment 2
A kind of Chinese medicine for treating rheumatism, its bulk drug weight composition are:In terms of 1000, adder tongue herb 900g, Herba adianti pedati 300g,
Szechwan-Yunnan sanicle herb 600g, adnate elder herb 500g, common sesbania root and leaf 300g, slenderstalk dicranostigma herb 700g, delavay habenaria root 600g, japanese pagodatree bark 800g, thorn are old
Crow 900g.
Essence for a better understanding of the present invention, further illustrated below by clinical testing data using the present invention
The beneficial effect of Chinese medicine:
The illness of Chinese medicine of the present invention is applicable, its clinical manifestation symptom:Rheumatic arthritis, osteoproliferation, sciatica, bone
Arthritis, neck-shoulder pain, lumbago and leg pain, scapulohumeral periarthritis, lumbar muscle strain, traumatic injury, muscle arthrosis swelling pain, extremity numbness, joint motion
Limited joint stuffiness, ankylosing spondylitis and all kinds of degenerative osteoarthropathies.
Test case standard:Meet the patient of above-mentioned clinical manifestation symptom.
Diagnostic criteria:It is strict by this in the clinical drug demonstration plan for treating rheumatism according to tcm treatment according to syndrome differentiation principle
The standard diagnostics of class disease, the relevant Chinese medicine clinical research principle developed and published according to the Ministry of Public Health, by therapeutic effect be divided into recovery from illness,
Significantly, it is effective and invalid judged.
Clinical data
216 patients for the treatment of group, and chosen and its symptom is similar compares according to each patients with clinical manifestations's symptom for the treatment of group
50 patients of group, under the conditions of identical treatment environment and same medicine, clinical trail treatment is carried out, record ratio is carried out to curative effect
It is right:
Treatment group totally 216, average age 42 years old, uses Chinese medicine of the present invention;
Control group totally 50, average age 45 years old, use the treatment preferable Yunnan hongyao capsule of rheumatism curative effect on the market;
Therapeutic effect:After medication one month, two groups of patient outcomes' statistics are as follows:
Treatment group:Recovery from illness 47%, notable 28%, effective 23%, invalid 2%.
Control group:Recovery from illness 14%, notable 18%, effective 11%, invalid 57%.
Statistics shows, the Chinese medicine of rheumatism is treated using the present invention, and in 216 patients, total effective rate is up to 98%, nothing
Efficiency only 2%, it is seen that its curative effect far superior to has medicine at present.
Follow-up observation 3 years after medication, are had no adverse reaction and toxic side effect using the patient of Chinese medicine of the present invention.
Model case is chosen below Chinese medicine of the present invention and effect is specifically described.
Model case one
Patient data:Korea Spro so-and-so, women is 55 years old, married, Han nationality, Linyi Hedong District zigzag street.
When medical symptoms include:Bilateral leg joint pain 25 years, was aggravated with arthroncus half a year.Go out in mid-May, 2017
Existing bilateral knee and hip arthralgia, rubescent and swelling is serious, and arthralgia is in discontinuity, with activity(Especially upper and lower building)Shi Ming
It is aobvious.Pain is attached most importance to right side, right knee joint swelling and it is movable when bilateral knee clicking of joint, swelling is in continuation, and degree is heavier, office
Portion is slightly rubescent, is limited with joint motion, and patient's readme is learnt, double knee joint chamber has joint fluid.
Usage and dosage:2 times/day of 2 tablets/time of warm water are swallowed
Using effect:Pain relief after patient takes medicine 3 days, continues after taking 1 week, and double knee swelling situations disappear.Patient continues to take
After the medicine 2 months, symptom when going to a doctor all disappears.
Model case two
Patient data:Text so-and-so, female, 37 years old, Linyi Fei County north of the city
When medical symptoms include:Patient before 9 years postpartum occur both hands metacarpophalangeal joints, proximal interphalangeal joint, double wrist joints, biped plantar toe close
Pain is saved, with swelling, morning stiffness, both hands can not be freely movable.Patient's chilly fear of wind, Low Back Pain are serious.
Usage and dosage:2 times/day of 2 tablets/time of warm water are swallowed
Using effect:Pain relief after patient takes medicine 5 days, continues after taking 2 weeks, and swelling situation disappears.Patient continues to take this
After medicine 3 months, freely, morning stiffness symptom disappears for both hands activity, and the double each symptoms of joint pain of knee of both hands all disappear.
Model case three
Patient data:Mr. Li, female, 68 years old, Linyi Lanshan District
When medical symptoms include:Patient's readme:Many places arthralgia 33 years repeatedly, pain adds when the exacerbation of in September, 2016, turning joint
Play, bilateral shoulder joint is predominantly located at, knee joint, wrist joint and metacarpal joint swelling are serious, are generated heat with interruption, body temperature 37.6-38
Degree Celsius, feel general malaise.By being diagnosed as to patient:Bilateral shoulder abduction and dorsiflexion are limited, and bilateral wrist joint swells
Swollen, Pi Wen is slightly higher, and articular pain is obvious, bilateral proximal interphalangeal joint flexion deformity, arthroncus, there is tenderness.Bilateral knee joint
Swelling, tenderness, joint flexing and dorsiflexion are limited.
Usage and dosage:3 times/day of 2 tablets/time of warm water are swallowed
Using effect:Pain relief after patient takes medicine 2 days, continues after taking 10 days, and swelling situation disappears.Patient continues to take this
After medicine 5 months, bilateral shoulder joint, knee joint, wrist joint and metacarpal joint pain and swelling disappear, and body temperature is normal, and shoulder joint, knee close
Section, wrist joint flexion-extension motion are freely.
Model case four
Patient data:Mr. Wang, man, 82 years old, Linyi Hedong District was peaceful
When medical symptoms include:Patient's double knee, double hips and lumbosacral regions pain repeatedly during 45 years, morning stiffness is obvious, and when have Wry Neck
Sense, limitation of activity.The small of the back, the stiff pain in sacrum portion, at bilateral articulatio sacroiliaca, bilateral inguinal and right knee pain, and with work
Dynamic limited, rainy days, the pain increased, and night turns over difficulty, and anemophobia is trembled with fear.Right knee, both hands arthroncus are serious.In November, 2016,
There is the migrans joint severe pain of whole body.
Usage and dosage:2 times/day of 2 tablets/time of warm water are swallowed
Using effect:The general joint pain such as the small of the back, sacrum portion mitigates after patient takes medicine 10 days, continues after taking 3 weeks, right knee swells
Swollen symptom disappears, and patient continued to take the medicine after 6 months, and general joint pain disappears simultaneously activity freely.
Claims (3)
1. a kind of Chinese medicine for treating rheumatism, it is characterised in that its bulk drug weight, which forms, is:In terms of 1000, adder tongue herb
700~900 g, the g of Herba adianti pedati 100~300,500~600g of szechwan-Yunnan sanicle herb, adnate elder herb 500~700 g, Xiang Tian
200~300g of centipede, 500~900g of slenderstalk dicranostigma herb, the g of delavay habenaria root 300~900,700~1000g of japanese pagodatree bark, japanese aralia bark
800~1000g.
2. Chinese medicine according to claim 1, it is characterised in that its bulk drug weight, which forms, is:In terms of 1000, bottle that is small
800 parts of grass, 200 parts of Herba adianti pedati, 500 parts of szechwan-Yunnan sanicle herb, 700 parts of adnate elder herb, 200 parts of common sesbania root and leaf, 900 parts of slenderstalk dicranostigma herb, chicken
900 parts of kidney ginseng, 1000 parts of japanese pagodatree bark, 1000 parts of japanese aralia bark.
3. Chinese medicine according to claim 1 or 2, it is characterised in that:Formulation is powder, pill or capsule.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711186272.5A CN107753749A (en) | 2017-11-24 | 2017-11-24 | A kind of Chinese medicine for treating rheumatism |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711186272.5A CN107753749A (en) | 2017-11-24 | 2017-11-24 | A kind of Chinese medicine for treating rheumatism |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107753749A true CN107753749A (en) | 2018-03-06 |
Family
ID=61276706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711186272.5A Pending CN107753749A (en) | 2017-11-24 | 2017-11-24 | A kind of Chinese medicine for treating rheumatism |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107753749A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103053752A (en) * | 2012-12-25 | 2013-04-24 | 蓝秀香 | Aralia mandshurica health protection tea |
CN104000890A (en) * | 2014-05-21 | 2014-08-27 | 山东中医药大学 | Traditional Chinese medicine for harmonizing liver and spleen, dispelling wind and eliminating dampness and nourishing blood and stopping throat pains |
CN104721561A (en) * | 2015-02-28 | 2015-06-24 | 朱海颖 | Traditional Chinese medicine for treating heat-toxin accumulation type traumatic chronic osteomyelitis and preparation method thereof |
CN106266896A (en) * | 2016-09-23 | 2017-01-04 | 房庆国 | A kind of invigorating primordial QI, kidney invigorating and YANG supporting, bone and muscle strengthening, the pill of curing rheumatism |
-
2017
- 2017-11-24 CN CN201711186272.5A patent/CN107753749A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103053752A (en) * | 2012-12-25 | 2013-04-24 | 蓝秀香 | Aralia mandshurica health protection tea |
CN104000890A (en) * | 2014-05-21 | 2014-08-27 | 山东中医药大学 | Traditional Chinese medicine for harmonizing liver and spleen, dispelling wind and eliminating dampness and nourishing blood and stopping throat pains |
CN104721561A (en) * | 2015-02-28 | 2015-06-24 | 朱海颖 | Traditional Chinese medicine for treating heat-toxin accumulation type traumatic chronic osteomyelitis and preparation method thereof |
CN106266896A (en) * | 2016-09-23 | 2017-01-04 | 房庆国 | A kind of invigorating primordial QI, kidney invigorating and YANG supporting, bone and muscle strengthening, the pill of curing rheumatism |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103055278B (en) | Medicament for treating rheumatism | |
CN103505659A (en) | Chinese proprietary medicine for treating rheumatoid arthritis | |
CN101708258A (en) | Medicament for treating bone damage | |
CN102228586A (en) | Ointment for promoting union of bone fractures and preparation method thereof | |
CN101912536B (en) | Medicinal composition for treating rheumatism and rheumatoid disease | |
CN102755571A (en) | Medicinal liquor and preparation process for treating rheumatism and rheumatoid | |
CN102240351B (en) | Traditional Chinese medicine for treating Arthritis, hyperosteogeny, cervical disc herniation and cervical spondylosis | |
CN104107288A (en) | Sinew-relaxing collateral-activating pill | |
CN104491828B (en) | A kind of temperature leads to Traditional Chinese medicine used as analgesic preparation and its paste preparation method | |
CN1151814C (en) | Composite Chinese medicine for treating rheumatic Bi syndrome | |
CN104306475B (en) | The medicine of a kind of mud stick treatment bone joint pain and processing method thereof | |
CN107753749A (en) | A kind of Chinese medicine for treating rheumatism | |
CN102600251B (en) | Rheumatism-rehabilitating traditional Chinese formulation | |
CN102302578A (en) | Medicament capable of eliminating dampness and relieving numbness and preparation method thereof | |
CN105412692A (en) | Traditional Chinese medicine preparation for treating arthroncus of knees | |
CN102048878A (en) | Plaster for assisting in treating rheumatic arthralgia and preparation method thereof | |
CN107320539A (en) | Pharmaceutical composition for treating disc herniation | |
CN102755487A (en) | Traditional Chinese medicine powder for eliminating dampness and invigorating blood circulation | |
CN101623460B (en) | Medicine for treating rheumatic pain and preparation method thereof | |
CN107469017A (en) | One kind chases after wind acesodyne capsule | |
CN101361934B (en) | Traditional Chinese medicine preparation for treating arthritis and various osteonosus | |
CN106822271A (en) | It is a kind of to treat pharmaceutical composition of rheumatic Bi syndrome and its production and use | |
CN101204436B (en) | Chinese patent medicine for curing hyperosteogeny in knee joint | |
CN101057951B (en) | Plaster for auxiliary curing rheumatoid disease and its preparing method | |
CN103990016B (en) | The Chinese medicine composition and its preparation and preparation method for the treatment of rheumatism bone disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180306 |